A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...

Pharmacists are integral to oncology care, optimizing treatment plans, managing adverse effects, and supporting precision medicine through collaborative practice agreements.

New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, ...

This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

Cancer treatment is no longer limited to standard protocols . The same drug, given in the same way, does not work for every ...

Hereditary breast cancer due to genetic mutations accounts for 5% to 10% of breast cancers. Breast cancer is the most ...

Research in non-small cell lung cancer (NSCLC) has made considerable strides in recent years, particularly in the context of ...

The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment ...

Scientists dug into paleofeces for a new study, learning some very intimate details about how long-ago people lived.

The CEO of $8.1 billion AI chips company Cerebras recently hit back at the idea entrepreneurs can launch an innovative business working “30, 40, 50 hours a week.” Aside from suggesting “every waking ...